Journal of neurologyHumansDiabetes MellitusType 2MaleFemale
Impact of GLP-1 receptor agonists on cranial nerve palsies in type 2 diabetes: a retrospective cohort study.
Ronak Bhatia, Huda Al-Bana, Khalid Mohamed, Chimezie Amaefuna, Stephanie Johnson, Banuja Munasinghe, Rawan Elkomi, Syed Fahad Gillani, Elizabeth Beyene, Mekdem Bisrat, Miriam Michael
Published: 202510.1007/s00415-025-13560-9
Abstract
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as key agents in managing type 2 diabetes mellitus (T2DM), with proven benefits in glycemic control, weight loss, and cardiovascular risk reduction. However, their neurologic…
Preview only. Read the full abstract at the source